TrialThe New England journal of medicine2022
Two Phase 3 Trials of Baricitinib for Alopecia Areata.
Brett King et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
226 papers cite itlatest 60 shown
this paperpooled ittrialcites it
TrialThe New England journal of medicine2022
Brett King et al.PubMed ↗Publisher ↗
No numbers read from the abstract.